Compare stocks

Bachem Holding AG is a Swiss-based company specializing in the development and manufacturing of peptides and oligonucleotides, primarily serving the pharmaceutical and biotechnology industries. With its expertise in this niche area, Bachem offers products including active pharmaceutical ingredients (APIs) and research chemicals. Founded in 1971, the company has positioned itself as a key supplier for both commercial and clinical-stage clients. Bachem has production sites in Switzerland, Germany, the United Kingdom, and the United States, allowing for a robust global presence. The company's strategic positioning benefits from its focus on high-quality, innovative manufacturing processes that comply with stringent regulatory standards.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.